Pilot Study "AHSP as a Biomarker of Sickle Cell Disease in a Population of Adults and Children"

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age3+

SponsorCentre Hospitalier de Saint-Denis

About this trial

Evaluation of AHSP concentration in total blood as a biomarker in adult and pediatric sickle cell patients

Adults: > 15 years and 6 months

Pediatrics: ≥ 3 years and ≤ 15 years and 6 months

Known SS or Sβ0 phenotypes

Hemoglobin disorder other than sickle cell disease (Criteria for Sickle Cell Patients)

Hemoglobinopathies other than sickle cell disease (Criteria for Control Patients)

Transfusion less than 3 months ago

Chronic active viral disease: hepatitis B, C, HIV

100 Participants

are divided into 4 treatment groups

Centre Hospitalier de Saint-Denis

Lead sponsor

Inserm U955

Collaborator